Joel Swirnoff

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Addition of dupilumab for patients with aspirin-exacerbated respiratory disease who have poor response to aspirin therapy after desensitization”.

Addition of dupilumab for patients with aspirin-exacerbated respiratory disease who have poor response to aspirin therapy after desensitization

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.08.032

N/A

0DataRank · unranked

2 citations

Joel Swirnoff, Rachel E Parigian, Tanya M. Laidlaw, Kathleen M. Buchheit, Pooja M. Achanta